Loading...
11 companies we cover
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| MCK | McKESSON CORPORATION | A | $101B | $866.64 | 23.23 | $411B | 1.1% |
| COR | CENCORA, INC. | A | $58.6B | $306.92 | 22.79 | $332.8B | 0.8% |
| CAH | Cardinal Health, Inc. | A | $51.2B | $220.22 | 30.46 | $254.2B | 0.7% |
| HSIC | HENRY SCHEIN, INC. | B | $9.6B | $86.37 | 25.18 | $13.6B | 3.0% |
| AHG | Akso Health Group | F- | $413.9M | $0.75 | 75.00 | $13.8M | -135.0% |
| FOCL | EDAP TMS SA | F- | $176.8M | $4.71 | — | $70.5M | -41.5% |
| ACH | Accendra Health, Inc. | F | $54.4M | $0.71 | — | $2.6B | -11.4% |
| COSM | COSMOS HEALTH INC. | F- | $35.4M | $0.35 | — | $73.7M | -33.1% |
| YI | 111, Inc. | D | $31.3M | $3.60 | — | $1.6B | -1.0% |
| MEDS | DataMeds AI, Inc. | D | $9.5M | $3.11 | — | $8M | -1,100.3% |
| HKPD | Cellyan Biotechnology Co., Ltd | C- | $1.8M | $0.11 | — | $16.4M | -4.3% |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.